AI Engines For more Details: Perplexity Kagi Labs You
Psoriasis:
Vitiligo:
Cutaneous T-Cell Lymphoma (CTCL):
Other Skin Disorders:
Photosensitivity Disorders:
Adverse Effects:
Precautions:
| Rank | Probiotic | Impact |
|---|---|---|
| species | Akkermansia muciniphila | Reduces |
| species | Bacteroides uniformis | Reduces |
| species | Escherichia coli | Reduces |
| species | Lacticaseibacillus paracasei | Reduces |
| species | Parabacteroides distasonis | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| ADHD | 1.3 | 1.3 | |
| Age-Related Macular Degeneration and Glaucoma | 0.4 | -0.4 | |
| Allergic Rhinitis (Hay Fever) | 1.8 | 0.9 | 1 |
| Allergies | 2.7 | 1.2 | 1.25 |
| Allergy to milk products | 1.2 | 1.3 | -0.08 |
| Alopecia (Hair Loss) | 0.1 | 0.1 | |
| Alzheimer's disease | 3.6 | 2 | 0.8 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.5 | 0.7 | 1.14 |
| Ankylosing spondylitis | 2 | 0.6 | 2.33 |
| Anorexia Nervosa | 0.9 | 1.4 | -0.56 |
| Antiphospholipid syndrome (APS) | 0.8 | 0.8 | |
| Asthma | 2.7 | 0.8 | 2.38 |
| Atherosclerosis | 1.7 | 0.3 | 4.67 |
| Atrial fibrillation | 1.6 | 1.5 | 0.07 |
| Autism | 3.1 | 3.7 | -0.19 |
| Autoimmune Disease | 0.9 | 0.2 | 3.5 |
| Barrett esophagus cancer | 0.3 | 0.3 | 0 |
| benign prostatic hyperplasia | 0.6 | 0.3 | 1 |
| Biofilm | 1.4 | 1.4 | |
| Bipolar Disorder | 1.5 | 1.5 | |
| Brain Trauma | 0.3 | 0.3 | 0 |
| Breast Cancer | 1.1 | 1.1 | |
| Cancer (General) | 0.3 | 0.4 | -0.33 |
| Carcinoma | 2.4 | 0.7 | 2.43 |
| Celiac Disease | 1.7 | 0.8 | 1.13 |
| Cerebral Palsy | 0.9 | 0.3 | 2 |
| Chronic Fatigue Syndrome | 1.9 | 0.7 | 1.71 |
| Chronic Kidney Disease | 1.4 | 0.1 | 13 |
| Chronic Lyme | 0.3 | -0.3 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 1.6 | 0.6 | 1.67 |
| Chronic Urticaria (Hives) | 1.6 | 0.9 | 0.78 |
| Coagulation / Micro clot triggering bacteria | 1.8 | 0.3 | 5 |
| Cognitive Function | 1 | 0.5 | 1 |
| Colorectal Cancer | 5 | 1 | 4 |
| Constipation | 0.9 | 0.9 | |
| Coronary artery disease | 1.4 | 0.9 | 0.56 |
| COVID-19 | 3.5 | 2.2 | 0.59 |
| Crohn's Disease | 4.3 | 1.9 | 1.26 |
| Cushing's Syndrome (hypercortisolism) | 0.3 | -0.3 | |
| cystic fibrosis | 1.1 | 0.3 | 2.67 |
| d-lactic acidosis (one form of brain fog) | 0.5 | 0.5 | |
| deep vein thrombosis | 2.4 | 0.6 | 3 |
| Denture Wearers Oral Shifts | 1.3 | 1.3 | |
| Depression | 4.8 | 3 | 0.6 |
| Dermatomyositis | 0.3 | 0.3 | |
| Eczema | 1.4 | 1.6 | -0.14 |
| Endometriosis | 2.1 | 0.5 | 3.2 |
| Eosinophilic Esophagitis | 0.3 | 0.3 | 0 |
| Epilepsy | 2.7 | 1 | 1.7 |
| erectile dysfunction | 1.4 | 1.4 | |
| Fibromyalgia | 1 | 1 | 0 |
| Functional constipation / chronic idiopathic constipation | 2.9 | 1.7 | 0.71 |
| gallstone disease (gsd) | 2.4 | 0.4 | 5 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.4 | 0.3 | 3.67 |
| Generalized anxiety disorder | 2.1 | 0.9 | 1.33 |
| giant cell arteritis | 0.2 | -0.2 | |
| Glioblastoma | 0.3 | -0.3 | |
| Gout | 0.7 | 0.3 | 1.33 |
| Graves' disease | 0.7 | 0.6 | 0.17 |
| Gulf War Syndrome | 0.5 | 0.9 | -0.8 |
| Halitosis | 1.4 | 0.3 | 3.67 |
| Hashimoto's thyroiditis | 1.3 | 0.4 | 2.25 |
| Heart Failure | 2.9 | 0.1 | 28 |
| hemorrhagic stroke | 0.7 | 0.7 | |
| Hidradenitis Suppurativa | 0.9 | 0.9 | |
| High Histamine/low DAO | 0.8 | 0.8 | |
| hypercholesterolemia (High Cholesterol) | 0.7 | 0.2 | 2.5 |
| hyperglycemia | 2.2 | 1 | 1.2 |
| Hyperlipidemia (High Blood Fats) | 0.1 | 0.1 | |
| hypertension (High Blood Pressure | 1.9 | 1.3 | 0.46 |
| Hypothyroidism | 0.1 | 0.1 | |
| Hypoxia | 2.2 | 2.2 | |
| IgA nephropathy (IgAN) | 1.3 | 0.7 | 0.86 |
| Inflammatory Bowel Disease | 4.8 | 2.7 | 0.78 |
| Insomnia | 1.1 | 0.8 | 0.38 |
| Intelligence | 1.4 | 0.1 | 13 |
| Intracranial aneurysms | 1 | 1 | |
| Irritable Bowel Syndrome | 3.4 | 1.8 | 0.89 |
| ischemic stroke | 1.5 | 0.9 | 0.67 |
| Liver Cirrhosis | 3.8 | 2.4 | 0.58 |
| Long COVID | 2.4 | 1.1 | 1.18 |
| Lung Cancer | 0.7 | 0.2 | 2.5 |
| Lymphoma | 0.6 | 0.6 | |
| Mast Cell Issues / mastitis | 1.4 | 1.4 | |
| ME/CFS with IBS | 0.5 | 0.3 | 0.67 |
| ME/CFS without IBS | 0.5 | 0.4 | 0.25 |
| membranous nephropathy | 0.3 | 0.3 | |
| Menopause | 0.3 | 0.1 | 2 |
| Metabolic Syndrome | 3.4 | 2.7 | 0.26 |
| Mood Disorders | 4.4 | 2.4 | 0.83 |
| multiple chemical sensitivity [MCS] | 0.9 | 0.9 | |
| Multiple Sclerosis | 2.6 | 2.1 | 0.24 |
| Multiple system atrophy (MSA) | 0.3 | 0.3 | |
| myasthenia gravis | 0.9 | 0.2 | 3.5 |
| neuropathic pain | 0.8 | -0.8 | |
| Neuropathy (all types) | 0.4 | 1 | -1.5 |
| neuropsychiatric disorders (PANDAS, PANS) | 0.8 | 0.8 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.7 | 0.5 | 4.4 |
| NonCeliac Gluten Sensitivity | 0.5 | 0.3 | 0.67 |
| Obesity | 3.7 | 4.3 | -0.16 |
| obsessive-compulsive disorder | 3.1 | 0.9 | 2.44 |
| Osteoarthritis | 2.1 | 0.7 | 2 |
| Osteoporosis | 1.1 | 0.7 | 0.57 |
| pancreatic cancer | 0.8 | 0.3 | 1.67 |
| Parkinson's Disease | 4.3 | 3 | 0.43 |
| Polycystic ovary syndrome | 2.8 | 0.9 | 2.11 |
| Postural orthostatic tachycardia syndrome | 0.2 | 0.2 | |
| Premenstrual dysphoric disorder | 0.4 | -0.4 | |
| primary biliary cholangitis | 0.3 | 1.1 | -2.67 |
| Primary sclerosing cholangitis | 1.5 | 0.7 | 1.14 |
| Psoriasis | 1.7 | 1.1 | 0.55 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 2.4 | 1.4 | 0.71 |
| Rosacea | 0.2 | -0.2 | |
| Schizophrenia | 2.1 | 1 | 1.1 |
| scoliosis | 0.5 | 0.5 | |
| Sjögren syndrome | 1.5 | 1.1 | 0.36 |
| Sleep Apnea | 0.3 | 0.3 | 0 |
| Slow gastric motility / Gastroparesis | 0.8 | 0.8 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 1.6 | 1.6 | |
| Stress / posttraumatic stress disorder | 1.8 | 0.9 | 1 |
| Systemic Lupus Erythematosus | 2.7 | 0.3 | 8 |
| Tic Disorder | 0.3 | 0.1 | 2 |
| Tourette syndrome | 0.4 | 0.3 | 0.33 |
| Type 1 Diabetes | 2.1 | 0.8 | 1.63 |
| Type 2 Diabetes | 3.2 | 3.2 | 0 |
| Ulcerative colitis | 3.9 | 2.3 | 0.7 |
| Unhealthy Ageing | 2 | 0.5 | 3 |
| Vitiligo | 1.6 | 0.7 | 1.29 |
